| - GRCh37:
- Chr19:17783275
- GRCh38:
- Chr19:17672466
| UNC13A | T61M | Amyotrophic lateral sclerosis | association (Mar 22, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr19:1041971
- GRCh38:
- Chr19:1041972
| ABCA7 | L101R | Amyotrophic lateral sclerosis | Uncertain significance (Nov 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202631985
- GRCh38:
- Chr2:201767262
| ALS2 | L48V | Amyotrophic lateral sclerosis | Likely pathogenic (Jul 1, 2022) | no assertion criteria provided |
| - GRCh37:
- Chr22:29879817-29879852
- GRCh38:
- Chr22:29483828-29483863
| NEFH | | Amyotrophic lateral sclerosis | Uncertain significance | no assertion criteria provided |
| - GRCh37:
- Chr5:179260046
- GRCh38:
- Chr5:179833046
| SQSTM1 | I173V, I257V | Inborn genetic diseases, Frontotemporal dementia and/or amyotrophic lateral sclerosis 1, Paget disease of bone 2, early-onset
| Uncertain significance (Oct 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:29884950
- GRCh38:
- Chr22:29488961
| NEFH | E441K | Inborn genetic diseases, not provided | Conflicting interpretations of pathogenicity (Oct 23, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr10:81915646
- GRCh38:
- Chr10:80155890
| ANXA11 | R461Q, R494Q | Amyotrophic lateral sclerosis, not provided | Uncertain significance (Jul 11, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:81928790-81928792
- GRCh38:
- Chr10:80169034-80169036
| ANXA11 | Q132del, Q165del | Amyotrophic lateral sclerosis | Uncertain significance (Jan 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:81926643
- GRCh38:
- Chr10:80166887
| ANXA11 | | Amyotrophic lateral sclerosis, not provided | Uncertain significance (Jun 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr21:33040876
- GRCh38:
- Chr21:31668563
| SOD1 | I150M | Amyotrophic lateral sclerosis | Likely pathogenic (Jan 1, 2022) | criteria provided, single submitter |
| - GRCh38:
- Chr9:27573529-27573534
| C9orf72, LOC109504728, LOC129929032 | | Amyotrophic lateral sclerosis | Uncertain significance (Jan 1, 2022) | criteria provided, single submitter |
| - GRCh38:
- Chr9:27573529-27573534
| C9orf72, LOC109504728, LOC129929032 | | Amyotrophic lateral sclerosis | Pathogenic (Jan 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220115207
- GRCh38:
- Chr2:219250485
| TUBA4A | V390G, V405G | Amyotrophic lateral sclerosis | Uncertain significance (Jan 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:135145054
- GRCh38:
- Chr9:132269667
| LOC126860782, SETX | I2412T | Amyotrophic lateral sclerosis | Uncertain significance (Jan 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:135147089
- GRCh38:
- Chr9:132271702
| SETX | | Amyotrophic lateral sclerosis | Uncertain significance (Jan 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:135203720
- GRCh38:
- Chr9:132328333
| SETX | V1089M | Amyotrophic lateral sclerosis | Uncertain significance (Jan 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:135205051
- GRCh38:
- Chr9:132329664
| SETX | F645Y | Amyotrophic lateral sclerosis | Uncertain significance (Jan 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:135205587
- GRCh38:
- Chr9:132330200
| SETX | I466M | Amyotrophic lateral sclerosis | Uncertain significance (Jan 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:4851604
- GRCh38:
- Chr17:4948309
| PFN1 | P29L | Amyotrophic lateral sclerosis, not provided | Uncertain significance (Feb 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:13154530
- GRCh38:
- Chr10:13112530
| OPTN | R149S | Amyotrophic lateral sclerosis | Uncertain significance (Jan 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138661301
- GRCh38:
- Chr5:139325612
| MATR3 | T436I, T486I, T774I | Amyotrophic lateral sclerosis | Uncertain significance (Jan 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:138643730
- GRCh38:
- Chr5:139308041
| MATR3 | Q209R | Amyotrophic lateral sclerosis | Uncertain significance (Jan 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52728869
- GRCh38:
- Chr3:52694853
| GLT8D1 | I370V | Amyotrophic lateral sclerosis | Uncertain significance (Jan 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:131296049
- GRCh38:
- Chr9:128533770
| GLE1, LOC101929270 | E489K | Amyotrophic lateral sclerosis | Uncertain significance (Jan 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:110048443
- GRCh38:
- Chr6:109727240
| FIG4 | R141W | Charcot-Marie-Tooth disease type 4, Amyotrophic lateral sclerosis, Inborn genetic diseases
| Uncertain significance (Sep 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:212251722
- GRCh38:
- Chr2:211386997
| ERBB4 | K1097E, K1113E | Amyotrophic lateral sclerosis | Uncertain significance (Jan 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:109278816
- GRCh38:
- Chr12:108885040
| DAO | G12R | Amyotrophic lateral sclerosis | Uncertain significance (Jan 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:2506578
- GRCh38:
- Chr16:2456577
| CCNF, LOC105371050 | V332M, V640M | Amyotrophic lateral sclerosis | Uncertain significance (Jan 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:2487202
- GRCh38:
- Chr16:2437201
| CCNF | R140Q | Amyotrophic lateral sclerosis, Inborn genetic diseases | Uncertain significance (Jan 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr14:102467322
- GRCh38:
- Chr14:102000985
| DYNC1H1 | Q1369R | Amyotrophic lateral sclerosis | Uncertain significance (Aug 7, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr2:202588052
- GRCh38:
- Chr2:201723329
| ALS2 | | Infantile-onset ascending hereditary spastic paralysis | Likely pathogenic (Aug 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:110048444
- GRCh38:
- Chr6:109727241
| FIG4 | R141Q | Charcot-Marie-Tooth disease type 4, Amyotrophic lateral sclerosis | Uncertain significance (Oct 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:94874779-94874784
- GRCh38:
- Chr9:92112497-92112502
| SPTLC1 | | Amyotrophic lateral sclerosis | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr19:17735631
- GRCh38:
- Chr19:17624822
| UNC13A | | Amyotrophic lateral sclerosis | Uncertain significance (Sep 9, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr20:60747782
- GRCh38:
- Chr20:62172726
| SS18L1 | A190T, A321T | Amyotrophic lateral sclerosis, not provided | Conflicting interpretations of pathogenicity (May 4, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr9:135203938
- GRCh38:
- Chr9:132328551
| SETX | I1016T | Inborn genetic diseases, Amyotrophic lateral sclerosis, Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2, Amyotrophic lateral sclerosis type 4 | Uncertain significance (Feb 8, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:150436517
- GRCh38:
- Chr5:151056956
| TNIP1 | A146V, A93V | Amyotrophic lateral sclerosis | Uncertain significance (Sep 9, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr9:135204560
- GRCh38:
- Chr9:132329173
| SETX | I809V | Amyotrophic lateral sclerosis | Uncertain significance (Sep 9, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr14:31164033
- GRCh38:
- Chr14:30694827
| SCFD1 | T248A, T341A, T366A, T374A, T433A | Amyotrophic lateral sclerosis | Uncertain significance (Sep 9, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr17:26712165
- GRCh38:
- Chr17:28385146
| SARM1 | Y501H | Amyotrophic lateral sclerosis | Uncertain significance (Sep 9, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr4:170523675
- GRCh38:
- Chr4:169602524
| NEK1 | N36S | Amyotrophic lateral sclerosis | Uncertain significance (Sep 9, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr22:29885638
- GRCh38:
- Chr22:29489649
| NEFH | V670E | Inborn genetic diseases, Amyotrophic lateral sclerosis, not provided
| Conflicting interpretations of pathogenicity (Jan 31, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:39544333
- GRCh38:
- Chr3:39502842
| MOBP | R172S, R196S | Amyotrophic lateral sclerosis | Uncertain significance (Sep 9, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr22:29693915
- GRCh38:
- Chr22:29297925
| EWSR1 | G409S, G464S, G465S, G470S | not provided, Amyotrophic lateral sclerosis | Conflicting interpretations of pathogenicity (Jun 1, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:29695693
- GRCh38:
- Chr22:29299703
| EWSR1 | D539N, D594N, D595N, D600N | Amyotrophic lateral sclerosis | Uncertain significance (Sep 9, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:212252677
- GRCh38:
- Chr2:211387952
| ERBB4 | M1059T | Amyotrophic lateral sclerosis | Uncertain significance (Sep 9, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40149254
- GRCh38:
- Chr17:41997236
| DNAJC7 | M1T, M57T | Amyotrophic lateral sclerosis | Uncertain significance (Sep 9, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr1:112309283
- GRCh38:
- Chr1:111766661
| DDX20 | L746S | Amyotrophic lateral sclerosis | Uncertain significance (Sep 9, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr21:45750684
- GRCh38:
- Chr21:44330801
| CFAP410 | A221T | Amyotrophic lateral sclerosis | Uncertain significance (Sep 9, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr12:111923123
- GRCh38:
- Chr12:111485319
| ATXN2 | I695L, I719L, I824L | Amyotrophic lateral sclerosis | Uncertain significance (Sep 9, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr12:109281281
- GRCh38:
- Chr12:108887505
| DAO | A84T | DAO-related condition, Amyotrophic lateral sclerosis | Conflicting interpretations of pathogenicity (Dec 13, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:74595249
- GRCh38:
- Chr2:74368122
| DCTN1 | I488F, I585F, I599F, I602F, I605F, I615F, I622F | Amyotrophic lateral sclerosis | Likely pathogenic (Jul 31, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:212248453
- GRCh38:
- Chr2:211383728
| ERBB4 | G1256R, G1272R | Amyotrophic lateral sclerosis | Likely pathogenic (Jul 31, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr14:31099759
- GRCh38:
- Chr14:30630553
| SCFD1 | I3T, I70T | Amyotrophic lateral sclerosis | Uncertain significance (Jul 31, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr12:112036782-112036783
- GRCh38:
- Chr12:111598978-111598979
| ATXN2, LOC130008791 | | Amyotrophic lateral sclerosis | risk factor (Jul 31, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr15:23086364-23086365
- GRCh38:
- Chr15:22786677-22786678
| LOC130056709, NIPA1 | | Amyotrophic lateral sclerosis | risk factor (Jul 31, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr15:44949373
- GRCh38:
- Chr15:44657175
| SPG11 | | Charcot-Marie-Tooth disease axonal type 2X, Amyotrophic lateral sclerosis, Amyotrophic lateral sclerosis type 5, Hereditary spastic paraplegia 11 | Conflicting interpretations of pathogenicity (Jul 18, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:202606527
- GRCh38:
- Chr2:201741804
| ALS2 | R741* | Infantile-onset ascending hereditary spastic paralysis | Pathogenic (Aug 25, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr21:33031996
- GRCh38:
- Chr21:31659683
| SOD1, SOD1-DT | | Amyotrophic lateral sclerosis, Amyotrophic lateral sclerosis type 1 | Uncertain significance (Jan 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:44925820
- GRCh38:
- Chr15:44633622
| SPG11 | R540C | Amyotrophic lateral sclerosis, Inborn genetic diseases, Amyotrophic lateral sclerosis type 5, Charcot-Marie-Tooth disease axonal type 2X, Hereditary spastic paraplegia 11 | Uncertain significance (Sep 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:78913136
- GRCh38:
- Chr15:78620794
| CHRNA3 | M1V | Amyotrophic lateral sclerosis | Likely pathogenic (Mar 31, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr15:78910978-78910979
- GRCh38:
- Chr15:78618636-78618637
| CHRNA3 | T83fs | Amyotrophic lateral sclerosis | Likely pathogenic (Mar 31, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr15:78894275-78894276
- GRCh38:
- Chr15:78601933-78601934
| CHRNA3 | I237fs | Amyotrophic lateral sclerosis | Likely pathogenic (Mar 31, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr15:78894259
- GRCh38:
- Chr15:78601917
| CHRNA3 | L242fs | Amyotrophic lateral sclerosis | Likely pathogenic (Mar 31, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr15:78894232
- GRCh38:
- Chr15:78601890
| CHRNA3 | P251R | Amyotrophic lateral sclerosis | Uncertain significance (Mar 31, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr12:49689173
- GRCh38:
- Chr12:49295390
| PRPH, TROAP-AS1 | R64* | Amyotrophic lateral sclerosis | Uncertain significance (Mar 31, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr7:94935670
- GRCh38:
- Chr7:95306358
| PON1 | Y236C | Amyotrophic lateral sclerosis | Uncertain significance (Mar 31, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr19:7620584
- GRCh38:
- Chr19:7555698
| PNPLA6 | G1010R, G972R, G1020R, G945R | Amyotrophic lateral sclerosis, Hereditary spastic paraplegia 39 | Uncertain significance (Jun 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:7605129
- GRCh38:
- Chr19:7540243
| PNPLA6 | G178C, G217C, G226C | Amyotrophic lateral sclerosis | Uncertain significance (Mar 31, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr6:110086229
- GRCh38:
- Chr6:109765026
| FIG4 | R483Q | not provided, Amyotrophic lateral sclerosis | Conflicting interpretations of pathogenicity (Jun 19, 2020) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr8:28017873
- GRCh38:
- Chr8:28160356
| ELP3 | R343H, R370H, R448H, R390H, R462H | Amyotrophic lateral sclerosis | Uncertain significance (Mar 31, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:74605312
- GRCh38:
- Chr2:74378185
| DCTN1 | R15C, R32C | Amyotrophic lateral sclerosis type 1, Perry syndrome, Neuronopathy, distal hereditary motor, type 7B, Amyotrophic lateral sclerosis | Conflicting interpretations of pathogenicity (Sep 1, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:74594495
- GRCh38:
- Chr2:74367368
| DCTN1 | L709P, L726P, L739P, L612P, L746P, L723P, L729P | Amyotrophic lateral sclerosis | Uncertain significance (Mar 31, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:74594488
- GRCh38:
- Chr2:74367361
| DCTN1 | D711E, D728E, D614E, D741E, D748E, D725E, D731E | Perry syndrome, Neuronopathy, distal hereditary motor, type 7B, Amyotrophic lateral sclerosis type 1, not provided, Amyotrophic lateral sclerosis | Uncertain significance (Jul 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:74593112
- GRCh38:
- Chr2:74365985
| DCTN1 | R798C, R912C, R895C, R925C, R932C, R915C, R909C | Perry syndrome, Neuronopathy, distal hereditary motor, type 7B, Amyotrophic lateral sclerosis type 1, DCTN1-related condition, Amyotrophic lateral sclerosis | Conflicting interpretations of pathogenicity (Aug 1, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr12:109294229
- GRCh38:
- Chr12:108900453
| DAO | G321E | Amyotrophic lateral sclerosis | Uncertain significance (Mar 31, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr12:109281243
- GRCh38:
- Chr12:108887467
| DAO | T71I | Amyotrophic lateral sclerosis | Uncertain significance (Mar 31, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr12:109278828
- GRCh38:
- Chr12:108885052
| DAO | A16T | DAO-related condition, Amyotrophic lateral sclerosis | Conflicting interpretations of pathogenicity (Feb 7, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr17:4851653
- GRCh38:
- Chr17:4948358
| PFN1 | A13T | Amyotrophic lateral sclerosis | Uncertain significance (Mar 31, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr4:170428877
- GRCh38:
- Chr4:169507726
| NEK1 | E562*, E634*, E564*, E590*, E606*, E537*, E589* | Amyotrophic lateral sclerosis | Uncertain significance (Mar 31, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr9:135163699
- GRCh38:
- Chr9:132288312
| SETX | R2083I | Amyotrophic lateral sclerosis type 4, Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2, Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2, Amyotrophic lateral sclerosis type 4, not provided, Amyotrophic lateral sclerosis
| Uncertain significance (Feb 8, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr14:21162046-21162047
- GRCh38:
- Chr14:20693887-20693888
| ANG, EGILA, RNASE4 | G109fs | Amyotrophic lateral sclerosis | Uncertain significance (Mar 31, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:212812268
- GRCh38:
- Chr2:211947543
| ERBB4 | R103H | not provided, ERBB4-related condition, Amyotrophic lateral sclerosis
| Conflicting interpretations of pathogenicity (Oct 19, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:212589887
- GRCh38:
- Chr2:211725162
| ERBB4 | G219S | Amyotrophic lateral sclerosis | Uncertain significance (Mar 31, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:212989553
- GRCh38:
- Chr2:212124828
| ERBB4 | Y53C | Amyotrophic lateral sclerosis | Uncertain significance (Mar 31, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:212295795
- GRCh38:
- Chr2:211431070
| ERBB4 | V840I | Amyotrophic lateral sclerosis | Uncertain significance (Mar 31, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr15:78927869
- GRCh38:
- Chr15:78635527
| CHRNB4 | R39L | Amyotrophic lateral sclerosis | Uncertain significance (Mar 31, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr15:78922149
- GRCh38:
- Chr15:78629807
| CHRNB4 | N166K | Amyotrophic lateral sclerosis | Benign (Mar 31, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr15:78921343
- GRCh38:
- Chr15:78629001
| CHRNB4 | A435V | Amyotrophic lateral sclerosis | Benign (Mar 31, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr20:61982107
- GRCh38:
- Chr20:63350755
| CHRNA4 | N219T, N43T | Amyotrophic lateral sclerosis | Uncertain significance (Mar 31, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr9:94812271
- GRCh38:
- Chr9:92049989
| SPTLC1 | R132*, R287*, R165* | not provided, Amyotrophic lateral sclerosis, Hereditary sensory and autonomic neuropathy type 1
| Uncertain significance (Jan 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:13175499
- GRCh38:
- Chr10:13133499
| OPTN | | Amyotrophic lateral sclerosis type 12, Glaucoma 1, open angle, E, Primary open angle glaucoma, not provided, Amyotrophic lateral sclerosis, Inborn genetic diseases
| Uncertain significance (Jan 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:61981784
- GRCh38:
- Chr20:63350432
| CHRNA4 | V151M, V327M | Autosomal dominant nocturnal frontal lobe epilepsy, Amyotrophic lateral sclerosis | Conflicting interpretations of pathogenicity (Dec 23, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr12:64875802
- GRCh38:
- Chr12:64482022
| TBK1 | | Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 8, Amyotrophic lateral sclerosis, Frontotemporal dementia and/or amyotrophic lateral sclerosis 4
| Pathogenic (Oct 5, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:64891001-64891003
- GRCh38:
- Chr12:64497221-64497223
| TBK1 | E643del | TBK1-related condition, Frontotemporal dementia and/or amyotrophic lateral sclerosis 4, not provided, Amyotrophic lateral sclerosis | Pathogenic/Likely pathogenic (May 25, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:212576777
- GRCh38:
- Chr2:211712052
| ERBB4 | H374Q | Amyotrophic lateral sclerosis, not provided, Amyotrophic lateral sclerosis type 19
| Conflicting interpretations of pathogenicity (Dec 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:31414830
- GRCh38:
- Chr2:31191964
| CAPN14 | L417F, L241F | not provided, Amyotrophic lateral sclerosis | Conflicting interpretations of pathogenicity (Sep 9, 2020) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr21:33039648
- GRCh38:
- Chr21:31667335
| SOD1 | S106L | Amyotrophic lateral sclerosis, Amyotrophic lateral sclerosis type 1 | Pathogenic (Oct 14, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:64868171
- GRCh38:
- Chr12:64474391
| TBK1 | | Amyotrophic lateral sclerosis, TBK1-related condition, Frontotemporal dementia and/or amyotrophic lateral sclerosis 4
| Pathogenic/Likely pathogenic (Dec 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:179251221
- GRCh38:
- Chr5:179824221
| SQSTM1 | G191R, G107R | Frontotemporal dementia and/or amyotrophic lateral sclerosis 1, Paget disease of bone 2, early-onset, Amyotrophic lateral sclerosis
| Uncertain significance (Jul 5, 2022) | criteria provided, multiple submitters, no conflicts |